What are the advantages of percutaneous transcatheter treatment over anticoagulant therapy for deep venous thrombosis (DVT)?

Updated: Oct 30, 2020
  • Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print


Thrombolytic therapy offers significant advantages over conventional anticoagulant therapy, including the prompt resolution of symptoms, the prevention of PE, the restoration of normal venous circulation, the preservation of venous valvular function, and the prevention of PTS. However, thrombolytic therapy does not prevent clot propagation, rethrombosis, or subsequent embolization. Heparin therapy and oral anticoagulant therapy must always follow a course of thrombolysis.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!